New Delhi: A group of top Indian pharma companies has reached out to the central government opposing a proposal to allow government-run Janaushadhi Kendras to dispense substitutes of prescription medications, …
Marksans, whose product portfolio includes therapeutic segments of cardiovascular, central nervous system, antidiabetic, pain management, gastroenterology and anti-allergy drugs and whose market capitalisation stood at Rs 5,299.75 crore in August last …
New Delhi On 8 November, the US Food and Drug Administration (FDA) approved the use of tirzepatide by US pharma company Eli Lilly exclusively for obesity management. The injectable tirzepatide …